UPDATE : Monday, September 16, 2019
상단여백
Boryung calls off ₩83-billion supply contract in Jordan
Boryung Pharmaceutical said that it has canceled its contract to supply 83 ...
by Lee Han-soo  |  2019-06-21 18:00
라인
MSD’s antibiotic Zerbaxa fails to get insurance coverage
MSD Korea’s antibiotic drug Zerbaxa Inj. failed to receive insurance covera...
by Kim Eun-young  |  2019-06-21 14:13
라인
‘Customized strategies needed for fast-changing Chinese drug regulation’
Foreign drugmakers need to make the most of China’s revised drug regulation...
by Jeong Sae-im  |  2019-06-21 14:12
라인
Off-label use of Mabthera Inj. denied
The Health Insurance Review and Assessment Service (HIRA) said it has disap...
by Kim Yun-mi  |  2019-06-20 15:49
라인
‘Korean cancer researchers have risen to world-class level’
The Korean Cancer Study Group (KCSG) said Korean institutions and researche...
by Kim Yun-mi  |  2019-06-20 15:04
라인
AbbVie unveils data from upadacitinib phase-3 studies of rheumatoid arthritis
AbbVie has recently announced the latest results from the phase 3 clinical ...
by Lee Han-soo  |  2019-06-19 16:27
라인
Hanmi launches osteoarthritis injection in US
Hanmi Pharmaceutical has launched Hyalrheuma, an hyaluronic acid (HA)- base...
by Lee Han-soo  |  2019-06-19 14:52
라인
Genexine to merge with Toolgen
Genexine and Toolgen have agreed to merge their businesses and become ToolG...
by Lee Han-soo  |  2019-06-19 14:24
라인
‘Keytruda will become most sold orphan drug worldwide by 2024’
The Korea Health Industry Development Institute (KHIDI) recently forecast t...
by Kim Yun-mi  |  2019-06-19 11:11
라인
ABL Bio releases latest data on Parkinson's disease treatment
ABL Bio said that it has presented its latest research result for ABL301, a...
by Lee Han-soo  |  2019-06-18 17:16
라인
‘Yuhan’s Lazertinib promising as 1st-line therapy for NSCLC’
Expectations are rising for Lazertinib, an investigational drug that Yuhan ...
by Jeong Sae-im  |  2019-06-18 14:43
라인
LEO Pharma Korea names new CEO
LEO Pharma Korea said Tuesday it appointed Shin Jung-beom as its new chief ...
by Lee Han-soo  |  2019-06-18 14:36
라인
SK Biopharmaceutical's sleepiness treatment commercially available in US
Jazz Pharmaceuticals, SK Biopharmaceutical's U.S. partner, announced th...
by Lee Han-soo  |  2019-06-18 13:42
라인
Korean biosimilars take on original drugs in Europe
Korean biosimilars are threatening original drugs with improved competitive...
by Jeong Sae-im  |  2019-06-17 15:26
라인
AstraZeneca to invest $630 million in Korean biohealth sector
AstraZeneca said it would invest $630 million into Korea’s biotech and heal...
by Kim Yun-mi  |  2019-06-17 11:33
라인
Daewoong to develop hearing loss treatment using ion-channel platform tech
Daewoong Pharmaceutical said that it has signed a contract with Yonsei Univ...
by Lee Han-soo  |  2019-06-14 17:27
라인
Lilly, AbbVie unveil new data for psoriasis treatment at global meet
Lilly and AbbVie have presented new data regarding their psoriasis treatmen...
by Lee Han-soo  |  2019-06-14 14:26
라인
LSK Global PS wins international recognition in clinical data management
LSK Global PS said it has obtained an international certification for clini...
by Lee Hye-seon  |  2019-06-13 14:30
라인
‘Many drugs won Chinese approval without review suspension’
Korean botulinum toxin maker Medytox is likely to face a delay in winning C...
by Jeong Sae-im  |  2019-06-13 11:26
라인
Daewoong’s botulinum toxin hits a snag in European approval
Daewoong Pharmaceutical is expected to face a delay in obtaining European a...
by Jeong Sae-im  |  2019-06-12 16:50
여백
여백
여백
Back to Top